(Former)
General clinical biochemistry, quality control, assay validation
Administration of staff, routine work and research
Establishment of biobanks
Design of biomarker monitoring trials phase I - IV
Cancer biomarkers
Networking at national and international level
Interpretation of serial protein cancer biomarker data i.e. CA 125, CA 15.3 and PSA in clinical studies
Criteria to interpret serial biomarker data investigated in pre-clinical computer based simulation studies
Circulating tumor cells
Hypermethylated DNA and metastatic breast cancer
Clinical utility of solid tumor epigenetics
Different approaches to assess the significance of a change in serial concentrations
As above
None
ID: 9898